RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...

Ideaya Biosciences (IDYA) announced it has entered into an additional clinical study collaboration and supply agreement with Gilead Sciences ...

The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

New Patent expands patent estate covering Adial's unique molecular genetic approach to diagnosing and potentially treating ...

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

Linvoseltamab is an investigational BCMAxCD3 bispecific antibody designed to bridge B-cell maturation antigen (BCMA) on MM cells with CD3-expressing T cells to facilitate T-cell activation and ...

Celltrion launches ADC cancer drug trials in U.S. while planning additional INDs Celltrion accelerates its global drug ...

DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Metastatic Breast Cancer pipeline landscape. It ...

But Trump takes it for granted that CBP manages to intercept just a small percentage of drug shipments, meaning that increased seizures are a sign of failure (indicating an increased supply ...

This generation’s experience also highlights how much more dangerous the drug supply has become. Despite better treatment and more resources to combat addiction, the overdose death rate among ...

Trump ordered a 90-day pause in foreign development assistance on January 20, the day he took the oath of office, pending assessments of efficiencies and consistency with US foreign policy.